Investors



  • FOR INFORMATION ON
    REPORTING CHANGES AND
    REVISED REVENUE GUIDANCE click here.


  • FOR GIVEN IMAGING
    ACQUISITION INFORMATION, click here.


  • FOR 2013 INVESTOR DAY MATERIALS,
    click here.


  • For Pharmaceuticals
    spin-off information,
    click here.


  • For tax basis information
    due to the Mallinckrodt spin,
    click here.


News Release

Printer Friendly Version View printer-friendly version
<< Back
Covidien and Mallinckrodt to Present at Deutsche Bank Conference

MANSFIELD, Mass.--(BUSINESS WIRE)--May. 23, 2013-- Covidien (NYSE: COV), a leading global provider of healthcare products, will present at the Deutsche Bank 38th Annual Health Care Conference in Boston on Wednesday and Thursday, May 29 and 30, 2013.

José E. Almeida, Chairman, President and Chief Executive Officer, will represent the Company in a session scheduled for May 30, 2013, at 12:00 p.m. ET.

Mark Trudeau, President, Pharmaceuticals, will discuss Mallinckrodt, the pharmaceuticals business of Covidien, in a session on May 29, 2013, scheduled to begin at 10:40 a.m. ET.

A live audio webcast of the presentations can be accessed at Covidien’s Investor Relations website: http://investor.covidien.com.

ABOUT COVIDIEN

Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2012 revenue of $11.9 billion, Covidien has 43,000 employees worldwide in 70 countries, and its products are sold in over 140 countries. Please visit www.covidien.com to learn more about our business.

Source: Covidien

Covidien
Jacqueline Strayer, 508-261-8305
Senior Vice President
Corporate Communications
jacqueline.strayer@covidien.com
or
Bruce Farmer, 508-452-4372
Vice President
Public Relations
bruce.farmer@covidien.com
or
Coleman Lannum, CFA, 508-452-4343
Vice President
Investor Relations
cole.lannum@covidien.com
or
Todd Carpenter, 508-452-4363
Senior Director
Investor Relations
todd.carpenter@covidien.com